Showing 2,641 - 2,660 results of 2,717 for search '"smoking cessation"', query time: 0.11s Refine Results
  1. 2641

    Cost-effectiveness of non-communicable disease prevention in Southeast Asia: a scoping review by Thi-Phuong-Lan Nguyen, M. Rifqi Rokhman, M. Rifqi Rokhman, Imre Stiensma, Rachmadianti Sukma Hanifa, The Due Ong, Maarten J. Postma, Maarten J. Postma, Maarten J. Postma, Jurjen van der Schans, Jurjen van der Schans, Jurjen van der Schans

    Published 2023-11-01
    “…The interventions ranged from screening and targeting specific groups for T2DM and CVDs to smoking cessation programs, discouragement of smoking or unhealthy diet through taxation, or health education. …”
    Get full text
    Article
  2. 2642

    Prevalence of smoking among employees of a university hospital Prevalencia del tabaquismo en funcionarios de un hospital universitario Prevalência do tabagismo em funcionários de u... by Isabel Cristina Echer, Ana Paula Almeida Corrêa, Amália de Fátima Lucena, Stephani Amanda Lukasewicz Ferreira, Marli Maria Knorst

    Published 2011-02-01
    “…Thus, taking into account the motivation of smokers to stop smoking, this is an appropriate time for health education and specific support to employees in the process of smoking cessation.<br>Estudio transversal con objetivo de identificar a prevalencia del tabaquismo en funcionarios de un hospital universitario del sur de Brasil. …”
    Get full text
    Article
  3. 2643

    Additive effects of adjunctive app-based interventions for mental disorders - A systematic review and meta-analysis of randomised controlled trials by Lukas M. Fuhrmann, Kiona K. Weisel, Mathias Harrer, Jennifer K. Kulke, Harald Baumeister, Pim Cuijpers, David D. Ebert, Matthias Berking

    Published 2024-03-01
    “…We found additive effects on symptoms of depression (g = 0.17; 95 % CI 0.02 to 0.33; k = 7 comparisons), anxiety (g = 0.80; 95 % CI 0.06 to 1.54; k = 3), mania (g = 0.2; 95 % CI 0.02 to 0.38; k = 4), smoking cessation (g = 0.43; 95 % CI 0.29 to 0.58; k = 10), and alcohol use (g = 0.23; 95 % CI 0.08 to 0.39; k = 7). …”
    Get full text
    Article
  4. 2644
  5. 2645

    Secondary Prevention and Quality of Life of Patients with Stable Coronary Heart Disease by E. D. Zharkova, Yu. V. Lukina, N. P. Kutishenko, E. T. Huseynova, N. P. Zolotareva, S. Yu. Martsevich, O. M. Drapkina

    Published 2023-05-01
    “…A healthy lifestyle (regular physical activity and smoking cessation) was achieved in 20.4% after 12 months of follow-up, the target level of LDL-c ˂ 1.8 mmol/L was achieved in 44.5% of patients, and the target blood pressure was achieved in 74,6%. …”
    Get full text
    Article
  6. 2646

    Active Smoking Before Liver Transplantation in Patients with Alcohol Use Disorder: Risk Factors and Outcomes by Ana Isabel López-Lazcano, Antoni Gual, Jordi Colmenero, Elsa Caballería, Anna Lligoña, Miquel Navasa, Gonzalo Crespo, Eva López, Hugo López-Pelayo

    Published 2020-08-01
    “…Quitting smoking before transplantation improved survival. Evidence based smoking cessation interventions should be offered before and after LT.…”
    Get full text
    Article
  7. 2647

    The Association Between Smartphone App–Based Self-monitoring of Hypertension-Related Behaviors and Reductions in High Blood Pressure: Systematic Review and Meta-analysis by Aikaterini Kassavou, Michael Wang, Venus Mirzaei, Sonia Shpendi, Rana Hasan

    Published 2022-07-01
    “…The review found the intervention had a small effect on supporting improvements in healthy diet by changing habits related to high sodium food (SMD –0.44, 95% CI –0.79 to –0.08) and a trend, although insignificant, toward supporting smoking cessation, low alcohol consumption, and better physical activity behaviors. …”
    Get full text
    Article
  8. 2648

    The Long-Term Effect of Smoking on 10 Years’ Survival and Success of Dental Implants: A Prospective Analysis of 453 Implants in a Non-University Setting by Simon Windael, Stijn Vervaeke, Stefanie De Buyser, Hugo De Bruyn, Bruno Collaert

    Published 2020-04-01
    “…The overall bone loss over time was significantly higher in smoking patients, which might be suggestive for a higher peri-implantitis risk. Hence, smoking cessation should be advised and maintained after implant placement from the perspective of peri-implant disease prevention.…”
    Get full text
    Article
  9. 2649

    A Multimethod Evaluation of Tobacco Treatment Trial Recruitment Messages for Current Smokers Recently Diagnosed With Cancer: Pilot Factorial Randomized Controlled Trial by Jordan M Neil, Christian Senecal, Lauren Ballini, Yuchiao Chang, Brett Goshe, Efren Flores, Jamie S Ostroff, Elyse R Park

    Published 2022-08-01
    “…Participants who received the proximal risks of continued smoking frame were significantly more likely to seek more information about participating (mean distal 4.83, SD 1.61 vs mean proximal 5.55, SD 1.15; P=.04), and those who received the losses of not participating frame reported significantly improved perceptions of smoking cessation research (mean gain 3.98, SD 0.83 vs mean loss 4.38, SD 0.78; P=.01). …”
    Get full text
    Article
  10. 2650
  11. 2651

    Meta-analysis of up to 622,409 individuals identifies 40 novel smoking behaviour associated genetic loci by Erzurumluoglu, AM, Liu, M, Jackson, VE, Barnes, DR, Datta, G, Melbourne, CA, Young, R, Batini, C, Surendran, P, Jiang, T, Adnan, SD, Afaq, S, Agrawal, A, Altmaier, E, Antoniou, AC, Asselbergs, FW, Baumbach, C, Bierut, L, Bertelsen, S, Boehnke, M, Bots, ML, Brazel, DM, Chambers, JC, Chang-Claude, J, Chen, C, Corley, J, Chou, Y-L, David, SP, de Boer, RA, de Leeuw, CA, Dennis, JG, Dominiczak, AF, Dunning, AM, Easton, DF, Eaton, C, Elliott, P, Evangelou, E, Faul, JD, Foroud, T, Goate, A, Gong, J, Grabe, HJ, Haessler, J, Haiman, C, Hallmans, G, Hammerschlag, AR, Harris, SE, Hattersley, A, Heath, A, Hsu, C, Iacono, WG, Kanoni, S, Kapoor, M, Kaprio, J, Kardia, SL, Karpe, F, Kontto, J, Kooner, JS, Kooperberg, C, Kuulasmaa, K, Laakso, M, Lai, D, Langenberg, C, Le, N, Lettre, G, Loukola, A, Luan, J, Madden, PAF, Mangino, M, Marioni, RE, Marouli, E, Marten, J, Martin, NG, McGue, M, Michailidou, K, Mihailov, E, Moayyeri, A, Moitry, M, Müller-Nurasyid, M, Naheed, A, Nauck, M, Neville, MJ, Nielsen, SF, North, K, Perola, M, Pharoah, PDP, Pistis, G, Polderman, TJ, Posthuma, D, Poulter, N, Qaiser, B, Rasheed, A, Reiner, A, Renström, F, Rice, J, Rohde, R, Rolandsson, O, Samani, NJ, Samuel, M, Schlessinger, D, Scholte, SH, Scott, RA, Sever, P, Shao, Y, Shrine, N, Smith, JA, Starr, JM, Stirrups, K, Stram, D, Stringham, HM, Tachmazidou, I, Tardif, J-C, Thompson, DJ, Tindle, HA, Tragante, V, Trompet, S, Turcot, V, Tyrrell, J, Vaartjes, I, van der Leij, AR, van der Meer, P, Varga, TV, Verweij, N, Völzke, H, Wareham, NJ, Warren, HR, Weir, DR, Weiss, S, Wetherill, L, Yaghootkar, H, Yavas, E, Jiang, Y, Chen, F, Zhan, X, Zhang, W, Zhao, W, Zhao, W, Zhou, K, Amouyel, P, Blankenberg, S, Caulfield, MJ, Chowdhury, R, Cucca, F, Deary, IJ, Deloukas, P, Di Angelantonio, E, Ferrario, M, Ferrières, J, Franks, PW, Frayling, TM, Frossard, P, Hall, IP, Hayward, C, Jansson, J-H, Jukema, JW, Kee, F, Männistö, S, Metspalu, A, Munroe, PB, Nordestgaard, BG, Palmer, CNA, Salomaa, V, Sattar, N, Spector, T, Strachan, DP, Understanding Society Scientific Group, EPIC-CVD, GSCAN, Consortium for Genetics of Smoking Behaviour, CHD Exome+ consortium, van der Harst, P, Zeggini, E, Saleheen, D, Butterworth, AS, Wain, LV, Abecasis, GR, Danesh, J, Tobin, MD, Vrieze, S, Liu, DJ, Howson, JMM

    Published 2019
    “…We tested up to 235,116 single nucleotide variants (SNVs) on the exome-array for association with smoking initiation, cigarettes per day, pack-years, and smoking cessation in a fixed effects meta-analysis of up to 61 studies (up to 346,813 participants). …”
    Journal article
  12. 2652
  13. 2653

    Respiratory tract infections and risk factors for infection in a cohort of 330 patients with axial spondyloarthritis or psoriatic arthritis by Natalie Frede, Eva Rieger, Raquel Lorenzetti, Alexandra Nieters, Ana C. Venhoff, Carolin Hentze, Marcus von Deimling, Nora Bartholomä, Jens Thiel, Jens Thiel, Reinhard E. Voll, Nils Venhoff

    Published 2022-10-01
    “…Hypogammaglobulinemia (IgG&lt;7g/l) was rare (3.4%) in this SpA cohort despite continuous immunomodulatory treatment.Awareness of these risk factors will assist physicians to identify patients with an increased infection risk, who will benefit from additional preventive measures, such as vaccination and smoking cessation or adjustment of DMARD therapy.…”
    Get full text
    Article
  14. 2654

    A Motivational Interviewing Chatbot With Generative Reflections for Increasing Readiness to Quit Smoking: Iterative Development Study by Andrew Brown, Ash Tanuj Kumar, Osnat Melamed, Imtihan Ahmed, Yu Hao Wang, Arnaud Deza, Marc Morcos, Leon Zhu, Marta Maslej, Nadia Minian, Vidya Sujaya, Jodi Wolff, Olivia Doggett, Mathew Iantorno, Matt Ratto, Peter Selby, Jonathan Rose

    Published 2023-10-01
    “…Participants’ readiness to quit was measured before the conversation and 1 week later using an 11-point scale that measured 3 attributes related to smoking cessation: readiness, confidence, and importance. …”
    Get full text
    Article
  15. 2655

    Argentine consensus recommendations for lung cancer screening programmes: a RAND/UCLA-modified Delphi study by Claudio Martin, Gonzalo Recondo, Javier Roberti, Ezequiel García Elorrio, Mònica Castro, Diego Kaen, Iris Boyeras, Mariana Seijo, Verónica Suárez, José Luis Morero, Ana Karina Patané, Sebastián Lamot, Ricardo Re, Artemio García, Patricia Vujacich, Alejandro Videla, Alfonso Fernández-Pazos, Gustavo Lyons, Hugo Paladini, Sergio Benítez, Sebastián Defranchi, Lisandro Paganini, Silvia Quadrelli, Sebastián Rossini, Edgardo Sobrino

    Published 2023-02-01
    “…Screening will be considered positive when finding a solid nodule ≥6 mm in diameter (or ≥113 mm3) on baseline LDCT and 4 mm in diameter if a new nodule is identified on annual screening. A smoking cessation programme should be offered, and cardiovascular risk assessment should be performed. …”
    Get full text
    Article
  16. 2656
  17. 2657

    Effectiveness of legislative actions against tobacco smoking regarding the reduction of in-hospital morbidity of angina pectoris and myocardial infarction in Russia as a whole and... by M. G. Gambaryan, A. V. Kontsevaya, T. A. Agishina, O. M. Drapkina

    Published 2021-10-01
    “…Also, hospital admission rates for angina and MI were associated with the changes in smoking cessation prevalence in 2013-2018 in the regions (β=-0,345; 95% CI, -0,67−-0,02 p=0,041) and smoking prevalence in 2019 (β=2,964; 95% CI, 1,28-5,92, p=0,049), respectively.Conclusion. …”
    Get full text
    Article
  18. 2658
  19. 2659

    Perfil e fatores associados ao sucesso terapêutico de tabagistas atendidos em um serviço público especializado [Profile and factors associated with successful treatment of smokers... by Sandro Rogerio dos Santos, Ana Rita de Cassia Bittencourt, Maria Helena de Castro Silva, Thaís Santos Guerra Stacciarini, Rosana Huppes Engel, Aldenora Laísa Paiva de Carvalho Cordeiro

    Published 2018-08-01
    “…ABSTRACT Objective: to profile smokers enrolled in the smoking cessation program of the Triangulo Mineiro Federal University (UFTM) in Uberaba, Minas Gerais, and to list the factors associated with successful treatment. …”
    Get full text
    Article
  20. 2660

    Factors Influencing the Length of Hospital Stay Among Patients with Chronic Obstructive Pulmonary Disease (COPD) in Macao Population: A Retrospective Study of Inpatient Health Reco... by Li M, Cheng K, Ku K, Li J, Hu H, Ung COL

    Published 2021-06-01
    “…The use of NIV (B=0.080, 95% CI:0.022&ndash; 0.138), pulmonary rehabilitation (B=0.269, 95% CI:0.212&ndash; 0.327), two and three types of inhaled medications (B=0.109, 95% CI:0.003&ndash; 0.166, B=0.255, 95% CI:0.083&ndash; 0.237) were significantly associated with longer LOS (P&lt; 0.05).Conclusion: NIV, PR and combined inhaled medications, which are often used for AECOPD, are the main clinical therapies associated with longer LOS in Macao. Smoking cessation, early treatments of comorbidities may be crucial to avoiding AECOPD and reducing LOS and disease burden.Keywords: chronic obstructive pulmonary disease, Macao, length of hospital stay, blood test results, clinical therapy, inhaled medications, acute exacerbation…”
    Get full text
    Article